Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy

Cervical cancer is one of the most common causes of cancer-related deaths in women worldwide. Despite advances in current therapies, women with advanced or recurrent disease present poor prognosis. Photodynamic therapy (PDT) has emerged as an effective therapeutic alternative to treat oncological di...

Full description

Bibliographic Details
Main Authors: Lucimara R. Carobeli, Lyvia E. de F. Meirelles, Gabrielle M. Z. F. Damke, Edilson Damke, Maria V. F. de Souza, Natália L. Mari, Kayane H. Mashiba, Cristiane S. Shinobu-Mesquita, Raquel P. Souza, Vânia R. S. da Silva, Renato S. Gonçalves, Wilker Caetano, Márcia E. L. Consolaro
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/12/2057
_version_ 1797501546496262144
author Lucimara R. Carobeli
Lyvia E. de F. Meirelles
Gabrielle M. Z. F. Damke
Edilson Damke
Maria V. F. de Souza
Natália L. Mari
Kayane H. Mashiba
Cristiane S. Shinobu-Mesquita
Raquel P. Souza
Vânia R. S. da Silva
Renato S. Gonçalves
Wilker Caetano
Márcia E. L. Consolaro
author_facet Lucimara R. Carobeli
Lyvia E. de F. Meirelles
Gabrielle M. Z. F. Damke
Edilson Damke
Maria V. F. de Souza
Natália L. Mari
Kayane H. Mashiba
Cristiane S. Shinobu-Mesquita
Raquel P. Souza
Vânia R. S. da Silva
Renato S. Gonçalves
Wilker Caetano
Márcia E. L. Consolaro
author_sort Lucimara R. Carobeli
collection DOAJ
description Cervical cancer is one of the most common causes of cancer-related deaths in women worldwide. Despite advances in current therapies, women with advanced or recurrent disease present poor prognosis. Photodynamic therapy (PDT) has emerged as an effective therapeutic alternative to treat oncological diseases such as cervical cancer. Phthalocyanines (Pcs) are considered good photosensitizers (PS) for PDT, although most of them present high levels of aggregation and are lipophilic. Despite many investigations and encouraging results, Pcs have not been approved as PS for PDT of invasive cervical cancer yet. This review presents an overview on the pathophysiology of cervical cancer and summarizes the most recent developments on the physicochemical properties of Pcs and biological results obtained both in vitro in tumor-bearing mice and in clinical tests reported in the last five years. Current evidence indicates that Pcs have potential as pharmaceutical agents for anti-cervical cancer therapy. The authors firmly believe that Pc-based formulations could emerge as a privileged scaffold for the establishment of lead compounds for PDT against different types of cervical cancer.
first_indexed 2024-03-10T03:19:59Z
format Article
id doaj.art-fe28c98e709e4a1799aa78a991642ffe
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T03:19:59Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-fe28c98e709e4a1799aa78a991642ffe2023-11-23T10:05:19ZengMDPI AGPharmaceutics1999-49232021-12-011312205710.3390/pharmaceutics13122057Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer PhototherapyLucimara R. Carobeli0Lyvia E. de F. Meirelles1Gabrielle M. Z. F. Damke2Edilson Damke3Maria V. F. de Souza4Natália L. Mari5Kayane H. Mashiba6Cristiane S. Shinobu-Mesquita7Raquel P. Souza8Vânia R. S. da Silva9Renato S. Gonçalves10Wilker Caetano11Márcia E. L. Consolaro12Department of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Chemistry, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Chemistry, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilDepartment of Clinical Analysis and Biomedicine, Universidade Estadual de Maringá, Maringá 87020-900, PR, BrazilCervical cancer is one of the most common causes of cancer-related deaths in women worldwide. Despite advances in current therapies, women with advanced or recurrent disease present poor prognosis. Photodynamic therapy (PDT) has emerged as an effective therapeutic alternative to treat oncological diseases such as cervical cancer. Phthalocyanines (Pcs) are considered good photosensitizers (PS) for PDT, although most of them present high levels of aggregation and are lipophilic. Despite many investigations and encouraging results, Pcs have not been approved as PS for PDT of invasive cervical cancer yet. This review presents an overview on the pathophysiology of cervical cancer and summarizes the most recent developments on the physicochemical properties of Pcs and biological results obtained both in vitro in tumor-bearing mice and in clinical tests reported in the last five years. Current evidence indicates that Pcs have potential as pharmaceutical agents for anti-cervical cancer therapy. The authors firmly believe that Pc-based formulations could emerge as a privileged scaffold for the establishment of lead compounds for PDT against different types of cervical cancer.https://www.mdpi.com/1999-4923/13/12/2057phthalocyanineuterine cervical neoplasmsphotochemotherapyin vitroin vivo
spellingShingle Lucimara R. Carobeli
Lyvia E. de F. Meirelles
Gabrielle M. Z. F. Damke
Edilson Damke
Maria V. F. de Souza
Natália L. Mari
Kayane H. Mashiba
Cristiane S. Shinobu-Mesquita
Raquel P. Souza
Vânia R. S. da Silva
Renato S. Gonçalves
Wilker Caetano
Márcia E. L. Consolaro
Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy
Pharmaceutics
phthalocyanine
uterine cervical neoplasms
photochemotherapy
in vitro
in vivo
title Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy
title_full Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy
title_fullStr Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy
title_full_unstemmed Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy
title_short Phthalocyanine and Its Formulations: A Promising Photosensitizer for Cervical Cancer Phototherapy
title_sort phthalocyanine and its formulations a promising photosensitizer for cervical cancer phototherapy
topic phthalocyanine
uterine cervical neoplasms
photochemotherapy
in vitro
in vivo
url https://www.mdpi.com/1999-4923/13/12/2057
work_keys_str_mv AT lucimararcarobeli phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT lyviaedefmeirelles phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT gabriellemzfdamke phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT edilsondamke phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT mariavfdesouza phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT natalialmari phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT kayanehmashiba phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT cristianesshinobumesquita phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT raquelpsouza phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT vaniarsdasilva phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT renatosgoncalves phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT wilkercaetano phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy
AT marciaelconsolaro phthalocyanineanditsformulationsapromisingphotosensitizerforcervicalcancerphototherapy